
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter C - Drugs: General
#### PART 201 - LABELING
##### Subpart G - Specific Labeling Requirements for Specific Drug Products
###### § 201.326 Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required warnings and other labeling.
####### Acetaminophen,Statement of identity.

(1)-(i)The statement of identity appears in accord with §§ 201.61 and 299.4 of this chapter. The ingredient name "acetaminophen" must appear highlighted (e.g., fluorescent or color contrast) or in bold type, be in lines generally parallel to the base on which the package rests as it is designed to be displayed, and be in one of the following sizes, whichever is greater:

(A) At least one-quarter as large as the size of the most prominent printed matter on the principal display panel (PDP), or

(B) At least as large as the size of the "Drug Facts" title, as required in § 201.66(d)(2). The presence of acetaminophen must appear as part of the established name of the drug, as defined in § 299.4 of this chapter. Combination products containing acetaminophen and a nonanalgesic ingredient(s) (e.g., cough-cold) must include the name "acetaminophen" and the name(s) of the other active ingredient(s) in the product on the PDP in accord with this paragraph. Only the name "acetaminophen" must appear highlighted or in bold type, and in a prominent print size, as described in this paragraph.
